Baxter Shares Plummet as Device Crisis Deepens

The medical technology firm Baxter International finds itself navigating a severe corporate storm, with challenges extending far beyond disappointing quarterly earnings. At the heart of the turmoil lies the Novum IQ Large Volume Pump, an infusion device allegedly linked to patient safety risks. As attorneys assemble class-action lawsuits, investors are questioning the company’s ability to survive this escalating nightmare.

When Baxter reported its quarterly results in late October, the financial impact of its operational troubles became starkly clear. Although the company posted improved adjusted earnings, it fell short of revenue expectations and was compelled to downgrade its full-year forecast. The market reaction was brutal: shares collapsed by more than 14 percent, Read more...